Medicare Enrolled
Dr. Sunil Rohatgi, MD
Hematology & Oncology · Lakeland, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rohatgi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rohatgi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rohatgi
Dr. Sunil Rohatgi is a hematology & oncology specialist in Lakeland, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Rohatgi performed 29,440 Medicare services across 1,529 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rohatgi received a total of $3,369 from 32 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rohatgi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 20% volume in FL
$3,369 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,440
Medicare services
Top 20% in FL for hematology & oncology
1,529
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,271 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
14,400 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 4,020 | $19 | $49 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,680 | $6 | $24 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,524 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,500 | $6 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 950 | $1 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $68 | $132 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
560 | $13 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
466 | $97 | $194 |
| Anti-nausea injection (ondansetron/Zofran) | 336 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
302 | $11 | $50 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
227 | $2 | $11 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
225 | $22 | $77 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
224 | $99 | $338 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
133 | $47 | $168 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
121 | $55 | $177 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
118 | $79 | $197 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
100 | $62 | $133 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
84 | $22 | $71 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
81 | $1 | $6 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $49 | $161 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
73 | $19 | $61 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
71 | $20 | $50 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
69 | $15 | $47 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $3 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $103 | $252 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
54 | $2 | $7 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
45 | $42 | $154 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $140 | $262 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
40 | $15 | $51 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
39 | $25 | $139 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $138 | $372 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $26 | $81 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $124 | $299 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
28 | $9 | $38 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.9% high complexity
91.5% medium
5.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,369
Total received (2018-2024)
Avg $674/year across 5 years
Bottom 45% in FL for hematology & oncology
32
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,028 (89.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,132
2023
$1,025
2022
$66
2020
$122
2018
$23
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$507
Novartis Pharmaceuticals Corporation
$452
Daiichi Sankyo Inc.
$247
GENZYME CORPORATION
$197
Blueprint Medicines Corporation
$191
Incyte Corporation
$180
AstraZeneca Pharmaceuticals LP
$149
E.R. Squibb & Sons, L.L.C.
$147
Janssen Biotech, Inc.
$147
Astellas Pharma US Inc
$140
Genentech USA, Inc.
$139
Gilead Sciences, Inc.
$80
ABBVIE INC.
$75
ARRAY BIOPHARMA INC
$71
SANOFI-AVENTIS U.S. LLC
$70
Coherus Biosciences Inc.
$64
Eisai Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$53
ADC Therapeutics America, Inc.
$47
Celgene Corporation
$42
SHIELD THERAPEUTICS INC
$37
Amgen Inc.
$31
SOBI, INC
$25
Myriad Genetic Laboratories, Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
Aveo Pharmaceuticals, Inc.
$22
GlaxoSmithKline, LLC.
$21
Stemline Therapeutics Inc.
$21
Karyopharm Therapeutics Inc.
$19
Verity Pharmaceuticals Inc.
$15
Lilly USA, LLC
$14
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFINITOR · AUGTYRO · AYVAKIT · BOSULIF · CABLIVI · CALQUENCE · DARZALEX · Doptelet · ELAHERE · ELITEK · ENHERTU · ERLEADA · Enhertu · FOTIVDA · IBRANCE · ICLUSIG · IMFINZI · INLYTA · JAKAFI · JAYPIRCA · KISQALI · Kadcyla · Kyprolis · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MYRISK · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Orserdu · PLUVICTO · Padcev · Perjeta · Polivy · Pomalyst · RYBREVANT · SARCLISA · Stivarga · TAFINLAR · TASIGNA · TECVAYLI · Tecentriq · Trelstar · Udenyca · VENCLEXTA · Vanflyta · XPOVIO · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $11 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
11
Per 100K population
1.4
County median income
$63,644
Nearest hospital
LAKELAND REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rohatgi is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rohatgi experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Rohatgi performed 14,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rohatgi receive payments from pharmaceutical companies?
Yes. Dr. Rohatgi received a total of $3,369 from 32 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rohatgi's costs compare to other hematology & oncology specialists in Lakeland?
Dr. Rohatgi's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rohatgi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lakeland
Browse hematology & oncology specialists in Lakeland ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology